Good afternoon, gentlemen. Thank you very much for coming here today.
Mr. Tang, I'm going to start with you, because very rarely do we have a medical practitioner, and as a pharmacist I thought I would start with you first.
You talked about the white paper you produced. One thing I found interesting, which I found even in my own practice, is the translational research component, which you've termed the “valley of death” because there's a lack of resources.
How do we get beyond that problem? We might be able to create a great piece of equipment or a great piece of software, but the transition to actually seeing it used clinically usually is very difficult.
What do you propose, on a medical basis, whereby we can get the benefit of all this technology but actually apply it usefully to help patients?